The evidence points toward an overall protective effect in adult cohorts and no increase in completed suicide in younger populations.
|Poll|May 22, 2018
Mini Quiz: Inflammation and Psychiatric Disorders
Author(s)Andrew H. Miller, MD
Because immunologic processes connected to psychiatric disorders have received considerable attention, we invite you to test your knowledge on the pathophysiologic process of depression and inflammation.
Advertisement
All of the following statements about depression and inflammation are true EXCEPT:
Advertisement
Related to this article
This study compared the efficacy and tolerability of the 5 second-generation antipsychotics that are currently FDA approved as adjunctive treatments for adults with MDD.
Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
TRD often mislabels depression; learn why MDD heterogeneity demands tailored treatments and when “difficult-to-treat” fits better.
First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Food Noise and GLP-1 Drugs: What Research Reveals About Motivation and Appetitive Drive
2
GLP-1 Receptor Agonists May Reinforce Restriction in Patients With Eating Disorders
3
Dementia Pipeline Update: Phase 2 and 3 Developments in Alzheimer Disease and Lewy Body Dementia
4
Psychedelic Trials Reveal Gaps Between Controlled Efficacy and Real-World Readiness
5